FLT3 and acute myeloid leukemia: Only 3 NPM1-mutated-AML were classified as favorable according to the molecular classifier and as intermediate or adverse according to the ELN classification because of high FLT3–ITD ratio (n = 2) or complex karyotype (n = 1).